Cargando…
Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance
Controlling reactive oxygen species (ROS) at sustainable levels can drive multiple facets of tumor biology, including within the cancer stem cell (CSC) population. Tight regulation of ROS is one key component in CSCs that drives disease recurrence, cell signaling, and therapeutic resistance. While R...
Autores principales: | Tuy, Kaysaw, Rickenbacker, Lucas, Hjelmeland, Anita B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212140/ https://www.ncbi.nlm.nih.gov/pubmed/34052208 http://dx.doi.org/10.1016/j.redox.2021.101953 |
Ejemplares similares
-
The redox-senescence axis and its therapeutic targeting
por: Ngoi, Natalie YL., et al.
Publicado: (2021) -
Immune cell - produced ROS and their impact on tumor growth and metastasis
por: Kennel, Kilian B., et al.
Publicado: (2021) -
PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
por: Hong, Ting, et al.
Publicado: (2021) -
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
por: Freire Boullosa, Laurie, et al.
Publicado: (2021) -
Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy
por: Petronek, M.S., et al.
Publicado: (2021)